Variables | Value or no. of patients |
---|---|
Age (years) | Â |
Mean ± SD | 42.06 ± 11.01 |
Sex | Â |
Female | 16 |
Male | 1 |
Lymphedema site (affected limb) | Â |
Right | 8 |
Left | 9 |
Clinical stage | Â |
2 | 10 |
3 | 7 |
Etiology | Â |
Primary | 5 |
Secondary | 12 |
Inguinal lymph node uptake | Â |
Absent | 7 |
Present | 10 |
Main lymphatic vessel | Â |
Absent | 13 |
Present | 4 |
Collateral vessel | Â |
Absent | 15 |
Present | 2 |
Dermal backflow | Â |
Absent | 5 |
Present | 12 |
1Â h LN uptake ratio | Â |
Mean ± SD | 0.39 ± 0.53 |
1Â h Extremity uptake ratio | Â |
Mean ± SD | 1.46 ± 0.50 |
1Â h Injection site clearance ratio | Â |
Mean ± SD | 1.04 ± 0.26 |
2Â h LN uptake ratio | Â |
Mean ± SD | 0.45 ± 0.61 |
2Â h Extremity uptake ratio | Â |
Mean ± SD | 1.42 ± 0.47 |
2Â h Injection site clearance ratio | Â |
Mean ± SD | 0.97 ± 0.13 |